Menu
GeneBe

X-19344053-G-A

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_000284.4(PDHA1):c.16G>A(p.Ala6Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,206,890 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A6A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000071 ( 0 hom., 2 hem., cov: 25)
Exomes 𝑓: 0.000016 ( 0 hom. 7 hem. )

Consequence

PDHA1
NM_000284.4 missense

Scores

1
5
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.13
Variant links:
Genes affected
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18768415).
BP6
Variant X-19344053-G-A is Benign according to our data. Variant chrX-19344053-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 803731.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000071 (8/112662) while in subpopulation AMR AF= 0.000649 (7/10784). AF 95% confidence interval is 0.000304. There are 0 homozygotes in gnomad4. There are 2 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PDHA1NM_000284.4 linkuse as main transcriptc.16G>A p.Ala6Thr missense_variant 1/11 ENST00000422285.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PDHA1ENST00000422285.7 linkuse as main transcriptc.16G>A p.Ala6Thr missense_variant 1/111 NM_000284.4 P1P08559-1

Frequencies

GnomAD3 genomes
AF:
0.0000710
AC:
8
AN:
112609
Hom.:
0
Cov.:
25
AF XY:
0.0000575
AC XY:
2
AN XY:
34769
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000650
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000572
AC:
1
AN:
174739
Hom.:
0
AF XY:
0.0000158
AC XY:
1
AN XY:
63289
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000131
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000165
AC:
18
AN:
1094228
Hom.:
0
Cov.:
29
AF XY:
0.0000194
AC XY:
7
AN XY:
361298
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000569
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000178
Gnomad4 OTH exome
AF:
0.0000218
GnomAD4 genome
AF:
0.0000710
AC:
8
AN:
112662
Hom.:
0
Cov.:
25
AF XY:
0.0000574
AC XY:
2
AN XY:
34832
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000649
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000416
ExAC
AF:
0.0000331
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pyruvate dehydrogenase E1-alpha deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeAug 16, 2022This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 6 of the PDHA1 protein (p.Ala6Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with PDHA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 803731). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 18, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.083
D
BayesDel_noAF
Benign
-0.12
Cadd
Benign
20
Dann
Uncertain
1.0
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.74
T;T;T;T;T;T;T;T
M_CAP
Pathogenic
0.73
D
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.50
D
MutationAssessor
Benign
0.84
L;L;L;.;.;L;.;.
MutationTaster
Benign
0.92
N;N;N;N;N
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.32
N;N;N;N;N;N;N;N
REVEL
Uncertain
0.40
Sift
Benign
0.43
T;T;T;T;T;T;T;T
Sift4G
Benign
0.54
T;T;T;T;T;T;T;T
Polyphen
0.0060
.;.;.;.;.;B;.;.
Vest4
0.44
MutPred
0.29
Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);
MVP
0.90
MPC
1.3
ClinPred
0.29
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.9
Varity_R
0.085
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs768396832; hg19: chrX-19362171; COSMIC: COSV100870322; API